TTRX offering history
Every offering-related filing in Turn Therapeutics Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 114 filings back to May 22, 2024.
| Date | Filing | What it means | |
|---|---|---|---|
| Apr 2, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 2, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 24, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 17, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 17, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Oct 29, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 9, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 8, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Sep 30, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 24, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 16, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Sep 2, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
TTRX offering FAQ
When did TTRX last execute an offering?
Per SEC filings, Turn Therapeutics Inc.'s most recent priced offering document is a 8-K filed 2026-03-24. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did TTRX last announce or register an offering?
The most recent registration is a S-1 filed 2025-10-09. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.